Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06867198 · ClinicalTrials.gov registry record · NA

Peanuts for Cardiometabolic, Brain, and Intestinal Health

A NA study of PreDiabetes and Cognition, sponsored by Georgia State University.

Recruiting
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT06867198: Recruiting NA study of PreDiabetes and Cognition, sponsored by Georgia State University.

NCT06867198 is a NA study of PreDiabetes and Cognition that is actively recruiting participants, run by Georgia State University. The registered enrollment target is 72 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06867198, a NA study of PreDiabetes and Cognition, is actively recruiting participants, sponsored by Georgia State University.

RECRUITING
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this 13-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.

Primary Outcome

Measurement of fasting blood glucose

Interventions

  • DIETARY_SUPPLEMENT Peanuts

Study Locations (1)

Georgia

  • Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2025-03
Est. Completion 2027-09
Phase NA
Georgia State University

45 total trials

What NCT06867198 shows while recruiting

NCT06867198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (90% lower).

The record links to 8 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Peanuts is the first listed.

NCT06867198 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06867198 about?

NCT06867198 is a clinical study titled "Peanuts for Cardiometabolic, Brain, and Intestinal Health". The overall objective of this 13-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.

What is the current status of trial NCT06867198?

This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-03. Estimated completion is 2027-09.

What conditions does trial NCT06867198 study?

This clinical trial studies the following conditions: PreDiabetes, Cognition, Adult, Gut -Microbiota, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance).

What interventions are being tested in trial NCT06867198?

The interventions under investigation include: Peanuts (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06867198?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06867198 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06867198's enrollment target sits among peer trials

72 78th of 149 higher than 72 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06867198, the US trial registry maintained by the National Library of Medicine. NCT06867198 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.